Serum IL-6 is a Prognostic Biomarker for Advanced Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
Lorenz Kocheise, Jan Kempski, Yunhe Tang, Lorenz Balcar, Victoria Berger, Miriam Tomczak, Joao Gorgulho, Ramsha Masood, Franziska Giehren,Constantin Schmidt,Jan P. Sutter, Throben W. Fruendt, Francesca Pagani, Sophie Wulf, Julian Kött, Saskia Domanig, Anastasios Giannou, Tanja Bedke, Jöran Lücke, Tao Zhang, Siwen Zhang, Andres Machicote, Ansgar Wilhelm Lohse,Marianna Alunni-Fabbroni, Jens Ricke,Najib Ben Khaled, Matthias Pinter, Bernhard Scheiner, Samuel Huber, Johann von Felden,Ignazio Piseddu,Kornelius Schulze Zeitschrift für Gastroenterologie（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper